- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Hengrui gets world-first okay for platelet drug hetrombopag | ||
| Fr | Andy Plump to step down as Takeda's R&D chief | ||
| Fr | AbbVie charts a new course for CGRPs in menstrual migraine | ||
| Fr | UK review recommends 'L plates' for new healthcare AIs | ||
| Fr | Encoded raises $275m for Dravet therapy and other financings | ||
| Do | Five indications added to Pharmacy First prescribing scheme | ||
| Do | Could UK clinical trial revamp unlock closer ties with Canada? | ||
| Do | Reviews underway of first drug for rare disease MOGAD | ||
| Do | Bayer moves Hyrnuo into frontline lung cancer treatment | ||
| Do | NICE says no to Gilead's lenacapavir for HIV PrEP | ||
| Mi | Amgen's Imdelltra scores again in small cell lung cancer | ||
| Mi | BMS eyes role for new CAR-T in post-BCMA multiple myeloma | ||
| Mi | FDA starts review of AZ's COPD blockbuster hope | ||
| Mi | FDA makes acting CDER, CBER chiefs permanent | ||
| Mi | Brainomix AI lends weight to Endeavor Bio's IPF trial data | ||
| Di | Pharvaris plans filings for HAE drug after pivotal trial win | ||
| Di | Sandoz says it is entering "golden decade" in biosimilars | ||
| Di | It turns out COPD may be a laughing matter after all | ||
| Di | Novartis falls sharply on another major R&D setback | ||
| Di | Pharma body sees 'green shoots' in UK investment | ||
| Mo | UK's Claret Capital raises €575m for European biotechs | ||
| Mo | Novo Nordisk's IL-6 drug flunks two more heart trials | ||
| Mo | Novartis hit as Lp(a) drug fails cardio outcomes trial | ||
| Mo | FDA overrides adcomm and approves AZ's oral SERD | ||
| Mo | Major trial of Roche Alzheimer's drug kicks off in Europe |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.